Overview

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics of golimumab in Japanese and Caucasian Males.
Phase:
Phase 1
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Antibodies, Monoclonal
Golimumab